Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
1.680
+0.020 (1.20%)
Dec 20, 2024, 4:00 PM EST - Market closed
Fate Therapeutics Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Fate Therapeutics stock have an average target of 6.75, with a low estimate of 5.00 and a high estimate of 10. The average target predicts an increase of 301.79% from the current stock price of 1.68.
Analyst Consensus: Hold
* Price targets were last updated on Aug 22, 2024.
Analyst Ratings
The average analyst rating for FATE stock from 10 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 2 | 2 | 2 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 9 | 8 | 8 | 8 | 6 | 6 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 13 | 13 | 13 | 11 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 19, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $5 | Hold | Reiterates | $5 | +197.62% | Aug 22, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 14, 2024 |
| Piper Sandler | Piper Sandler | Hold → Buy Upgrades $4 → $6 | Hold → Buy | Upgrades | $4 → $6 | +257.14% | Jun 17, 2024 |
Financial Forecast
Revenue This Year
13.53M
from 63.53M
Decreased by -78.70%
Revenue Next Year
4.02M
from 13.53M
Decreased by -70.30%
EPS This Year
-1.72
from -1.64
EPS Next Year
-1.73
from -1.72
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 21.0M | 21.0M | 21.0M | |||
| Avg | 13.5M | 4.0M | 3.4M | |||
| Low | 10.1M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -66.9% | 55.2% | 422.5% | |||
| Avg | -78.7% | -70.3% | -15.4% | |||
| Low | -84.1% | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -1.24 | -0.84 | -0.99 | |||
| Avg | -1.72 | -1.73 | -1.45 | |||
| Low | -2.57 | -2.06 | -2.16 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.